ACEP-话题@MedSci

#ACEP#

38篇内容 | 480人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1779330, encodeId=85551e79330da, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Stroke：症状性颈动脉狭窄患者血小板粘附抑制剂Revacept的疗效, objectType=article, longId=729284, objectId=02a9e29284cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02a9e29284cb, replyNumber=0, likeNumber=36, createdTime=2022-12-29, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02a9e29284cb, moduleTitle=Stroke：症状性颈动脉狭窄患者血小板粘附抑制剂Revacept的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02a9e29284cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778954, encodeId=e31d1e78954aa, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Stroke：症状性颈动脉狭窄患者血小板粘附抑制剂Revacept的疗效, objectType=article, longId=729284, objectId=02a9e29284cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02a9e29284cb, replyNumber=0, likeNumber=49, createdTime=2022-07-25, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02a9e29284cb, moduleTitle=Stroke：症状性颈动脉狭窄患者血小板粘附抑制剂Revacept的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02a9e29284cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779328, encodeId=334d1e79328c5, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=NEJM：白介素-1阻滞剂Rilonacept用于复发性心包炎的治疗, objectType=article, longId=205454, objectId=6ca6205454ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ca6205454ce, replyNumber=0, likeNumber=40, createdTime=2021-06-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ca6205454ce, moduleTitle=NEJM：白介素-1阻滞剂Rilonacept用于复发性心包炎的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ca6205454ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778951, encodeId=7e321e78951a0, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号, objectType=article, longId=197668, objectId=c43e19e6680f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c43e19e6680f, replyNumber=0, likeNumber=47, createdTime=2021-02-23, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c43e19e6680f, moduleTitle=白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c43e19e6680f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779329, encodeId=51961e79329c4, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=J Clin Oncol：Abatacept协同刺激阻断可明显有效预防急性GVHD！, objectType=article, longId=206294, objectId=1ff32062949d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ff32062949d, replyNumber=0, likeNumber=29, createdTime=2021-05-15, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ff32062949d, moduleTitle=J Clin Oncol：Abatacept协同刺激阻断可明显有效预防急性GVHD！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ff32062949d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778953, encodeId=cd5e1e7895342, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=J Clin Oncol：Abatacept协同刺激阻断可明显有效预防急性GVHD！, objectType=article, longId=206294, objectId=1ff32062949d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ff32062949d, replyNumber=0, likeNumber=34, createdTime=2021-04-30, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ff32062949d, moduleTitle=J Clin Oncol：Abatacept协同刺激阻断可明显有效预防急性GVHD！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ff32062949d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778949, encodeId=3edf1e789496c, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=EULAR 2020：头对头III期研究证实AbbVie的JAK1抑制剂upadacitinib治疗类风湿关节炎，优于CTLA-4-Fc融合蛋白abatacept, objectType=article, longId=195490, objectId=a38e195490b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a38e195490b9, replyNumber=0, likeNumber=38, createdTime=2020-11-13, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a38e195490b9, moduleTitle=EULAR 2020：头对头III期研究证实AbbVie的JAK1抑制剂upadacitinib治疗类风湿关节炎，优于CTLA-4-Fc融合蛋白abatacept, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a38e195490b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779327, encodeId=70801e79327d4, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号, objectType=article, longId=197668, objectId=c43e19e6680f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c43e19e6680f, replyNumber=0, likeNumber=40, createdTime=2020-12-13, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c43e19e6680f, moduleTitle=白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c43e19e6680f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778952, encodeId=5d7d1e7895263, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=NEJM：白介素-1阻滞剂Rilonacept用于复发性心包炎的治疗, objectType=article, longId=205454, objectId=6ca6205454ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ca6205454ce, replyNumber=0, likeNumber=46, createdTime=2021-12-23, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ca6205454ce, moduleTitle=NEJM：白介素-1阻滞剂Rilonacept用于复发性心包炎的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ca6205454ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779326, encodeId=e0ad1e79326b5, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Contraception：研究：避孕不当，让人变胖！, objectType=article, longId=196045, objectId=97ae196045aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97ae196045aa, replyNumber=0, likeNumber=40, createdTime=2020-11-03, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97ae196045aa, moduleTitle=Contraception：研究：避孕不当，让人变胖！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97ae196045aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779325, encodeId=4d711e79325f8, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=EULAR 2020：头对头III期研究证实AbbVie的JAK1抑制剂upadacitinib治疗类风湿关节炎，优于CTLA-4-Fc融合蛋白abatacept, objectType=article, longId=195490, objectId=a38e195490b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a38e195490b9, replyNumber=0, likeNumber=35, createdTime=2020-06-12, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a38e195490b9, moduleTitle=EULAR 2020：头对头III期研究证实AbbVie的JAK1抑制剂upadacitinib治疗类风湿关节炎，优于CTLA-4-Fc融合蛋白abatacept, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a38e195490b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778950, encodeId=5a071e78950a7, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Contraception：研究：避孕不当，让人变胖！, objectType=article, longId=196045, objectId=97ae196045aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97ae196045aa, replyNumber=0, likeNumber=34, createdTime=2021-03-15, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97ae196045aa, moduleTitle=Contraception：研究：避孕不当，让人变胖！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97ae196045aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778948, encodeId=f3d81e78948f9, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Eur J Contracept Reprod Health Care：宫内节育器的使用是否会提高外阴念珠菌病的发生风险, objectType=article, longId=188693, objectId=696818869392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=696818869392, replyNumber=0, likeNumber=27, createdTime=2020-10-06, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=696818869392, moduleTitle=Eur J Contracept Reprod Health Care：宫内节育器的使用是否会提高外阴念珠菌病的发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=696818869392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779324, encodeId=92b11e79324ba, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Eur J Contracept Reprod Health Care：宫内节育器的使用是否会提高外阴念珠菌病的发生风险, objectType=article, longId=188693, objectId=696818869392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=696818869392, replyNumber=0, likeNumber=37, createdTime=2020-10-07, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=696818869392, moduleTitle=Eur J Contracept Reprod Health Care：宫内节育器的使用是否会提高外阴念珠菌病的发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=696818869392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778946, encodeId=bbb41e78946e0, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=2019 ACEP：免疫治疗引起的胃肠道不良反应给急诊科医师带来了新的挑战, objectType=article, longId=182361, objectId=532a182361b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=532a182361b4, replyNumber=0, likeNumber=38, createdTime=2020-09-28, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=532a182361b4, moduleTitle=2019 ACEP：免疫治疗引起的胃肠道不良反应给急诊科医师带来了新的挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=532a182361b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778947, encodeId=64761e78947af, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=2019年美国心脏协会科学会议：Rilonacept治疗复发性心包炎的II期临床数据, objectType=article, longId=183160, objectId=386c183160e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=386c183160e6, replyNumber=0, likeNumber=32, createdTime=2020-05-22, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=386c183160e6, moduleTitle=2019年美国心脏协会科学会议：Rilonacept治疗复发性心包炎的II期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=386c183160e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779322, encodeId=a10f1e793222c, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=2019 ACEP：免疫治疗引起的胃肠道不良反应给急诊科医师带来了新的挑战, objectType=article, longId=182361, objectId=532a182361b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=532a182361b4, replyNumber=0, likeNumber=32, createdTime=2020-06-27, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=532a182361b4, moduleTitle=2019 ACEP：免疫治疗引起的胃肠道不良反应给急诊科医师带来了新的挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=532a182361b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779323, encodeId=3c691e793235f, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=2019年美国心脏协会科学会议：Rilonacept治疗复发性心包炎的II期临床数据, objectType=article, longId=183160, objectId=386c183160e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=386c183160e6, replyNumber=0, likeNumber=35, createdTime=2020-01-07, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=386c183160e6, moduleTitle=2019年美国心脏协会科学会议：Rilonacept治疗复发性心包炎的II期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=386c183160e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778945, encodeId=ed011e7894551, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=2018 ACEP临床实践指南：急诊室内操作时应用丙泊酚镇静（更新版）, objectType=article, longId=160576, objectId=79431605e6f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79431605e6f6, replyNumber=0, likeNumber=23, createdTime=2019-06-28, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79431605e6f6, moduleTitle=2018 ACEP临床实践指南：急诊室内操作时应用丙泊酚镇静（更新版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79431605e6f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779321, encodeId=3d6c1e7932169, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=2018 ACEP临床实践指南：急诊室内操作时应用丙泊酚镇静（更新版）, objectType=article, longId=160576, objectId=79431605e6f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79431605e6f6, replyNumber=0, likeNumber=21, createdTime=2019-04-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79431605e6f6, moduleTitle=2018 ACEP临床实践指南：急诊室内操作时应用丙泊酚镇静（更新版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79431605e6f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACEP

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

Stroke：症状性颈动脉狭窄患者血小板粘附抑制剂Revacept的疗效

2022-12-29

仁医06 (审核中...)

前往app查看评论内容

#ACEP#

Stroke：症状性颈动脉狭窄患者血小板粘附抑制剂Revacept的疗效

2022-07-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

NEJM：白介素-1阻滞剂Rilonacept用于复发性心包炎的治疗

2021-06-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号

2021-02-23

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

J Clin Oncol：Abatacept协同刺激阻断可明显有效预防急性GVHD！

2021-05-15

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

J Clin Oncol：Abatacept协同刺激阻断可明显有效预防急性GVHD！

2021-04-30

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

EULAR 2020：头对头III期研究证实AbbVie的JAK1抑制剂upadacitinib治疗类风湿关节炎，优于CTLA-4-Fc融合蛋白abatacept

2020-11-13

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号

2020-12-13

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

NEJM：白介素-1阻滞剂Rilonacept用于复发性心包炎的治疗

2021-12-23

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

Contraception：研究：避孕不当，让人变胖！

2020-11-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

EULAR 2020：头对头III期研究证实AbbVie的JAK1抑制剂upadacitinib治疗类风湿关节炎，优于CTLA-4-Fc融合蛋白abatacept

2020-06-12

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

Contraception：研究：避孕不当，让人变胖！

2021-03-15

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

Eur J Contracept Reprod Health Care：宫内节育器的使用是否会提高外阴念珠菌病的发生风险

2020-10-06

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

Eur J Contracept Reprod Health Care：宫内节育器的使用是否会提高外阴念珠菌病的发生风险

2020-10-07

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

2019 ACEP：免疫治疗引起的胃肠道不良反应给急诊科医师带来了新的挑战

2020-09-28

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

2019年美国心脏协会科学会议：Rilonacept治疗复发性心包炎的II期临床数据

2020-05-22

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

2019 ACEP：免疫治疗引起的胃肠道不良反应给急诊科医师带来了新的挑战

2020-06-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

2019年美国心脏协会科学会议：Rilonacept治疗复发性心包炎的II期临床数据

2020-01-07

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

2018 ACEP临床实践指南：急诊室内操作时应用丙泊酚镇静（更新版）

2019-06-28

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

2018 ACEP临床实践指南：急诊室内操作时应用丙泊酚镇静（更新版）

2019-04-25

科室
- - 订阅+
  - 更多科室
工具
服务